S3758-119

Reported

End Veterans Overdose Act of 2026

119th Congress Introduced Feb 2, 2026

Summary

What This Bill Does

The End Veterans Overdose Act requires the Department of Veterans Affairs to make covered opioid overdose rescue medications available at VA pharmacies to veterans and their caregivers. It is a targeted harm-reduction bill that makes naloxone-style rescue medication easier to obtain through VA rather than relying on separate community access.

Who Benefits and How

Veterans at overdose risk benefit from easier access to rescue medications through VA pharmacies. Veteran caregivers benefit because they can obtain medication needed to reverse an overdose in an emergency. VA clinicians benefit from a clear statutory pathway to connect patients and caregivers with overdose rescue medication. Veterans treatment programs benefit when overdose prevention is integrated into VA pharmacy access.

Who Bears the Burden and How

VA pharmacies must stock or provide covered opioid overdose rescue medications. VA pharmacists must counsel veterans and caregivers on medication use. VA clinicians must identify veterans and caregivers who should receive rescue medication. Federal taxpayers bear medication and implementation costs.

Key Provisions

  • Requires VA to make covered overdose rescue medications available at VA pharmacies.
  • Covers both veterans and their caregivers.
  • Uses VA pharmacy access to improve opioid overdose prevention.
  • Creates implementation duties for VA pharmacists and clinicians.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Requires VA pharmacies to make opioid overdose rescue medications available to veterans and caregivers.

Key Policy Areas

Veterans, Health Care, Drug Policy

Primary Purpose

Requires VA pharmacies to make opioid overdose rescue medications available to veterans and caregivers.

Policy Domains

Veterans Health Care Drug Policy

Bill provisions

Identified Gains
  • Veterans at overdose risk
  • Veteran caregivers
  • VA clinicians
  • Veterans treatment programs
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
VA clinicians:
Veteran caregivers:
Veterans at overdose risk:
Veterans treatment programs:
Identified Costs
  • VA pharmacies
  • VA pharmacists
  • VA clinicians
  • Federal taxpayers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
VA clinicians:
VA pharmacies:
VA pharmacists:
Federal taxpayers:

Legislative Progress

Reported
Introduced Committee Passed
Mar 18, 2026

Committee on Veterans' Affairs. Ordered to be reported with an …

Feb 2, 2026

Read twice and referred to the Committee on Veterans' Affairs.

Feb 2, 2026

Introduced in Senate

Feb 2, 2026

Mrs. Shaheen (for herself and Mr. Crapo) introduced the following …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Veterans
1 mention across 1 clause
+1 positive

Veterans at overdose risk

Caregivers
1 mention across 1 clause
+1 positive

Veteran caregivers

Healthcare
1 mention across 1 clause
-1 negative

VA clinicians

Government
1 mention across 1 clause
-1 negative

VA pharmacies

Taxpayers
1 mention across 1 clause
-1 negative

Taxpayers

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Veterans Health Care Drug Policy
Actor Mappings
"secretary"
→ Secretary of Veterans Affairs

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology